Search Results

Filter
  • 1-10 of  34 results for ""Angiotensin II Type 1 Receptor Blockers""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effects of Candesartan in the Acute Phase of Intracerebral Hemorrhage.

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2019 Aug; Vol. 28 (8), pp. 2262-2267. Date of ElectronicPublisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Hemilingual Angioedema after Thrombolysis in a Patient on an Angiotensin II Receptor Blocker.

  • Authors : Diestro JDB; Department of Neurosciences, College of Medicine and Philippine General Hospital, University of the Philippines Manila, Manila, Philippines. Electronic address: .; Sedano LSP

Subjects: Angioedema/Angioedema/Angioedema/*chemically induced ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*adverse effects ; Fibrinolytic Agents/Fibrinolytic Agents/Fibrinolytic Agents/*adverse effects

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2019 May; Vol. 28 (5), pp. e44-e45. Date of Electronic Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Improvement of Plasma Biomarkers after Switching Stroke Patients from Other Angiotensin II Type I Receptor Blockers to Olmesartan.

  • Authors : Tada Y; Department of Neurosurgery, Institute of Health Biosciences, Tokushima University, Tokushima, Japan. Electronic address: .; Yagi K

Subjects: Drug Substitution*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2015 Jul; Vol. 24 (7), pp. 1487-92. Date of Electronic Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Protective effect of telmisartan against progressive oxidative brain damage and synuclein phosphorylation in stroke-resistant spontaneously hypertensive rats.

  • Authors : Fukui Y; Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.; Yamashita T

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use ; Benzoates/Benzoates/Benzoates/*therapeutic use

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2014 Jul; Vol. 23 (6), pp. 1545-53. Date of Electronic Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Telmisartan reduces progressive oxidative stress and phosphorylated α-synuclein accumulation in stroke-resistant spontaneously hypertensive rats after transient middle cerebral artery occlusion.

  • Authors : Sato K; Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Kitaku, Okayama, Japan.; Yamashita T

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use ; Benzoates/Benzoates/Benzoates/*therapeutic use

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2014 Jul; Vol. 23 (6), pp. 1554-63. Date of Electronic Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Renin-angiotensin system blockade safely reduces blood pressure in patients with minor ischemic stroke during the acute phase.

  • Authors : Nakamura T; Department of Neurology, Tokyo Women's Medical University, Tokyo, Japan. ; Tsutsumi Y

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*administration & dosage ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*administration & dosage ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2010 Nov-Dec; Vol. 19 (6), pp. 435-40. Date of Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Olmesartan, an angiotensin II receptor blocker, restores cerebral hypoperfusion in elderly patients with hypertension.

  • Authors : Nagata R; Department of Neurology, Toho University Omori Medical Center, Tokyo 143-8541, Japan.; Kawabe K

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Cerebrovascular Circulation/Cerebrovascular Circulation/Cerebrovascular Circulation/*drug effects

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2010 May; Vol. 19 (3), pp. 236-240.Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Antiplatelet effect of losartan and telmisartan in patients with ischemic stroke.

  • Authors : Yamada K; Department of Neurology, St Marianna University School of Medicine, Kawasaki, Japan. ; Hirayama T

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*therapeutic use ; Benzoates/Benzoates/Benzoates/*therapeutic use

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2007 Sep-Oct; Vol. 16 (5), pp. 225-31.Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.

  • Authors : Kono S; Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Kitaku, Okayama, Japan.; Kurata T

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*pharmacology ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*pharmacology

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2015 Mar; Vol. 24 (3), pp. 537-47. Date of Electronic Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Telmisartan reduces progressive accumulation of cellular amyloid beta and phosphorylated tau with inflammatory responses in aged spontaneously hypertensive stroke resistant rat.

  • Authors : Kurata T; Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.; Lukic V

Subjects: Amyloid beta-Peptides/Amyloid beta-Peptides/Amyloid beta-Peptides/*metabolism ; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*pharmacology

  • Source: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2014 Nov-Dec; Vol. 23 (10), pp. 2580-2590. Date of Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  34 results for ""Angiotensin II Type 1 Receptor Blockers""